Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Update Il y a 5 ans
Reference: NCT01815307

Woman and Man

  • | Country :
  • Japan
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare efficacy and safety of Gemcitabine versus S-1 adjuvant therapy after hemihepatectomy.


Inclusion criteria

  • Biliary tract cancer

Links